Fascinating incident pointed out in HART Group's recent reanalysis of the AstraZeneca trials:

The same month the company noted their second serious adverse event of transverse myelitis (inflammation of the spinal cord), they also CANCELLED a study that planned to further look at adverse events...

I summarised the rest of their key findings here via https://starknakedbrief.substack.com/p/reanalysis-of-the-astrazeneca-trials

@TheStarkNakedBrief